Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib.
Guan J, Fransson S, Siaw JT, Treis D, Van den Eynden J, Chand D, Umapathy G, Ruuth K, Svenberg P, Wessman S, Shamikh A, Jacobsson H, Gordon L, Stenman J, Svensson PJ, Hansson M, Larsson E, Martinsson T, Palmer RH, Kogner P, Hallberg B. Guan J, et al. Among authors: svenberg p. Cold Spring Harb Mol Case Stud. 2018 Aug 1;4(4):a002550. doi: 10.1101/mcs.a002550. Print 2018 Aug. Cold Spring Harb Mol Case Stud. 2018. PMID: 29907598 Free PMC article.
Temporal changes in incidence of relapse and outcome after relapse of childhood acute lymphoblastic leukemia over three decades; a Nordic population-based cohort study.
Jensen KS, Oskarsson T, Lähteenmäki PM, Flaegstad T, Jónsson ÓG, Svenberg P, Schmiegelow K, Heyman M, Norén-Nyström U, Schrøder H, Albertsen BK. Jensen KS, et al. Among authors: svenberg p. Leukemia. 2022 May;36(5):1274-1282. doi: 10.1038/s41375-022-01540-1. Epub 2022 Mar 21. Leukemia. 2022. PMID: 35314777
Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.
Nordlander A, Mattsson J, Ringdén O, Leblanc K, Gustafsson B, Ljungman P, Svenberg P, Svennilson J, Remberger M. Nordlander A, et al. Among authors: svenberg p. Biol Blood Marrow Transplant. 2004 Mar;10(3):195-203. doi: 10.1016/j.bbmt.2003.11.002. Biol Blood Marrow Transplant. 2004. PMID: 14993885 Free article.
Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia.
Zetterquist H, Mattsson J, Uzunel M, Näsman-Björk I, Svenberg P, Tammik L, Bayat G, Winiarski J, Ringdén O. Zetterquist H, et al. Among authors: svenberg p. Bone Marrow Transplant. 2000 Apr;25(8):843-51. doi: 10.1038/sj.bmt.1702337. Bone Marrow Transplant. 2000. PMID: 10808205
Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases.
Ringdén O, Remberger M, Svenberg P, Svahn BM, Dahllöf G, Gustafsson B, Hassan Z, Omazic B, Uzunel M, Aschan J, Barkholt L, Winiarski J, Ljungman P, Mattsson J. Ringdén O, et al. Among authors: svenberg p. Bone Marrow Transplant. 2007 Apr;39(7):383-8. doi: 10.1038/sj.bmt.1705602. Epub 2007 Feb 19. Bone Marrow Transplant. 2007. PMID: 17310137
18 results